[Federal Register Volume 72, Number 141 (Tuesday, July 24, 2007)]
[Notices]
[Pages 40338-40339]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-14291]


-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice 07-053]


Notice of Intent To Grant Exclusive License

AGENCY: National Aeronautics and Space Administration.

[[Page 40339]]


ACTION: Notice of Intent To Grant Exclusive License.

-----------------------------------------------------------------------

SUMMARY: This notice is issued in accordance with 35 U.S.C. 209(c)(1) 
and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to 
grant an exclusive license worldwide to practice the invention 
described and claimed in U.S. Patent No. 7,179,217, entitled 
``Apparatus for Enhancing Tissue Repair in Mammals'', to Regenetech, 
Inc., having its principal place of business in Houston, Texas. The 
patent is jointly owned by NASA and Regenetech. The NASA-owned patent 
rights in this invention have been assigned to the United States of 
America as represented by the Administrator of the National Aeronautics 
and Space Administration. The prospective exclusive license will comply 
with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.

DATES: The prospective exclusive license may be granted unless, within 
fifteen (15) days from the date of this published notice, NASA receives 
written objections including evidence and argument that establish that 
the grant of the license would not be consistent with the requirements 
of 35 U.S.C. 209 and 37 CFR 404.7. Competing applications completed and 
received by NASA within fifteen (15) days of the date of this published 
notice will also be treated as objections to the grant of the 
contemplated exclusive license.
    Objections submitted in response to this notice will not be made 
available to the public for inspection and, to the extent permitted by 
law, will not be released under the Freedom of Information Act, 5 
U.S.C. 552.

ADDRESSES: Objections relating to the prospective license may be 
submitted to Patent Counsel, Office of Chief Counsel, Mail Code AL, 
2101 NASA Parkway, Houston, TX 77058, (281) 483-4871; (281) 483-6936 
[Facsimile].

FOR FURTHER INFORMATION CONTACT: Theodore U. Ro, Patent Attorney, 
Office of Chief Counsel, Johnson Space Center, Mail Code AL, 2101 NASA 
Parkway, Houston, TX 77058, (281) 244-7148; (281) 483-6936 [Facsimile]. 
Information about other NASA inventions available for licensing can be 
found online at http://technology.nasa.gov/.

     Dated: July 18, 2007.
Keith T. Sefton,
Deputy General Counsel, Administration and Management.
 [FR Doc. E7-14291 Filed 7-23-07; 8:45 am]
BILLING CODE 7510-13-P